BA

Healthcare · Pharmaceuticals

Balaxi Pharmaceuticals Ltd (BALAXI)

₹33.57

Mkt cap
₹129 Cr
P/E ratio
38.40
P/B
0.73
Div yield
0.00%
ROE
0.59%
ROCE
3.47%
EPS (TTM)
₹0.87
Book value
₹46
52W range
15–41
Sector
Healthcare

Price history

Previous close

Balaxi Pharmaceuticals Ltd is an IPR-based pharmaceutical Company engaged in producing, stocking, selling, and supplying branded and generic medicines. [1]

NSE BALAXI
Health check
Mixed
ValuationFair
ProfitabilityWeak
GrowthHigh
TechnicalsNeutral
52-week range
−18.08% from high
₹34
₹15+120.86% from low₹41
Current
₹33.57
Prev close
₹37.30
Day
−10.00%
Price performance
1D
−10.00%
1W
+43.22%
1M
+59.86%
3M
+50.54%
6M
+34.07%
1Y
−10.31%
YTD
+24.06%

Financials

Revenue, profit & margin
P/E ratio
38.4×
BALAXI is 13% above the sector median of 34.0×
BALAXI38.4×
Sector median34.0×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales54.7260.7959.8365.6277.3873.2976.2770.7456.1872.5470.7180.6881.37
YoY Sales growth-36.65%-29.79%-25.84%-0.52%+41.41%+20.56%+27.48%+7.80%-27.40%-1.02%-7.29%+14.05%+44.84%
Expenses43.9647.1446.3655.5366.7969.3063.7266.5855.0269.4570.5976.0276.24
Operating Profit10.7613.6513.4710.0910.593.9912.554.161.163.090.124.665.13
OPM %19.66%22.45%22.51%15.38%13.69%5.44%16.45%5.88%2.06%4.26%0.17%5.78%6.30%
Other Income5.931.51-0.70-1.85-4.113.94-1.69-1.781.590.102.92-0.99-0.83
Interest0.370.410.610.370.451.380.741.010.891.020.990.730.86
Depreciation0.660.480.670.490.460.480.460.460.480.560.650.851.42
Profit before tax15.6614.2711.497.385.576.079.660.911.381.611.402.092.02
Tax %7.92%4.77%4.87%12.06%17.41%11.70%10.56%67.03%84.06%80.75%56.43%38.28%43.07%
Net Profit14.4313.5910.936.484.595.368.640.290.210.310.611.301.15
EPS in Rs2.822.652.011.170.830.971.570.050.040.060.110.240.21
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +2.87% · closed higher next day 2 of last 2
 Q1FY27Q2FY27
Broadcast5 Aug '2612 Nov '26
Earnings day+0.58%+5.16%
+1 day+0.71%+3.40%
+5 days+0.08%+64.53%
+15 days−6.74%—
+30 days−4.12%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
65.99%Promoter
Promoters65.99%
FIIs0.00%
DIIs2.56%
Public31.45%
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,880.0036.664,51,0750.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,442.0088.893,03,7490.26%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,670.0081.821,77,6320.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,424.0097.751,30,9720.08%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,189.9026.201,18,6930.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,380.0041.171,15,2670.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,391.8036.211,12,4420.93%852−35.05%7,404−2.44%15.49%
Balaxi Pharma₹23.4438.401290.00%1+447.62%81+44.84%3.47%
Median: 160 Co.₹465.8333.992,0120.08%13+33.53%179+20.92%14.94%

Filings